Clinical Trial Update: Caffeine for Apnea of Prematurity (CAP) [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating caffeine citrate for apnea of prematurity has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Apnea of Prematurity

Drugs mentioned

• Caffeine citrate (caffeine citrate)

Snippet

Sponsor: McMaster University | Conditions: Apnea of Prematurity | Phase 3 | Status: COMPLETED